Summary Orforglipron and Retatrutide represent two powerful but distinct approaches to treating obesity and metabolic disease
The website offers a coverage lookup tool and various ways to save on Wegovy for those with or without insurance
According to the World Health Organization (WHO), approximately 254 million people were living with chronic hepatitis B and 50 million people with chronic hepatitis C globally in 2022
AJOVY should be discontinued if signs or symptoms of Raynaud's phenomenon develop and patients should be evaluated by a healthcare provider if symptoms do not resolve
These mechanisms are reported in available scientific literature and are presented for informational purposes only, within a research context
Ingold I, Aichler M, Yefremova E, Roveri A, Buday K, Doll S et al (2015) Expression of a catalytically inactive mutant form of glutathione peroxidase 4 (Gpx4) confers a dominant-negative effect in male fertility